Live recombinant vaccines using genetically engineered vaccinia virus
- 31 December 1985
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 5, 301-307
- https://doi.org/10.1016/s0166-3542(85)80042-5
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Vaccinia Virus Recombinants: Expression of VSV Genes and Protective Immunization of Mice and CattleScience, 1985
- Expression of rabies virus glycoprotein from a recombinant vaccinia virusNature, 1984
- Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene.Proceedings of the National Academy of Sciences, 1984
- Plasmodium knowlesi Sporozoite Antigen: Expression by Infectious Recombinant Vaccinia VirusScience, 1984
- Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D.Proceedings of the National Academy of Sciences, 1984
- Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters.Proceedings of the National Academy of Sciences, 1983
- Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin.Proceedings of the National Academy of Sciences, 1983
- Infectious vaccinia virus recombinants that express hepatitis B virus surface antigenNature, 1983
- Vaccinia virus: a selectable eukaryotic cloning and expression vector.Proceedings of the National Academy of Sciences, 1982
- Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus.Proceedings of the National Academy of Sciences, 1982